<DOC>
	<DOCNO>NCT03105687</DOCNO>
	<brief_summary>By conduct SPPA trial try find , whether personalize Short Message Service ( SMS ) reminder blood pressure-lowering medication effectively increase patient ' adherence blood pressure-lowering medication . Additionally , also evaluate effect patient ' systolic blood pressure control .</brief_summary>
	<brief_title>Effectiveness SMS Reminders Blood Pressure-lowering Drugs Intake</brief_title>
	<detailed_description>Hypertension belong main risk factor cardiovascular disease , lead cause morbidity mortality world Slovak Republic . Despite availability effective antihypertensive treatment , blood pressure control remain serious problem . Poor adherence blood pressure-lowering medication consider key factor uncontrolled blood pressure . Studies estimate overall adherence medication patient chronic disease around 50 % . Slovak study report even significantly low adherence rate ( 15-19 % ) , underlines urgency address health problem Slovak Republic . The majority intervention aim increase patient ' adherence associate substantial cost health care professional capacity , lack current Slovak health care system . Several study show efficiency SMS reminder improve patient ' adherence health outcomes low cost . Since mobile phone frequently use among Slovak inhabitant SMS message popular mean communication , approach could feasible also Slovakia . Pharmacists highly trained drug expert knowledge , skill time address patient ' nonadherence use simple SMS reminder system . Thus , research question follow : Do personalized daily SMS reminder blood pressure-lowering medication intake provide pharmacist addition standard Pharmaceutical Care reduce proportion nonadherence blood pressure-lowering medication among old ambulatory patient hypertension Slovakia ? And hypothesize personalized daily SMS reminder blood pressure-lowering medication intake provide pharmacist addition standard Pharmaceutical Care increase proportion adherence blood pressure-lowering medication among old ambulatory patient hypertension Slovakia 30 % 49 % intervention group compare control group .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Age â‰¥ 55 year ( day 55. birthday inclusive ) Diagnosis primary ( essential ) hypertension ( I10 accord International Classification Diseases ( ICD10 ) ) Filling blood pressurelowering prescription ( ) trial recruitment ( Visit 1 ) Duration antihypertensive drug treatment least 1 year without discontinuation Ownership mobile phone personal use ability open read SMS Understanding Slovak language nativespeaker level Informed consent participation clinical trial personally sign Informed Consent Form Exclusion criterion assess prior patient enrolment ( trial pharmacist ) : Planned hospitalisation trial period ( 3 month ) Biological impairment affect ability read SMS ( e.g . loss vision , visual field cut , aphasia ) Living household another trial participant Participation another clinical trial Exclusion criterion assess patient enrolment ( trial pharmacist project leader ) : Hospitalisation trial period Patient inform he/she wo n't able participate trial Withdrawal Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>mHealth</keyword>
	<keyword>SMS reminder</keyword>
	<keyword>adherence</keyword>
	<keyword>antihypertensive drug</keyword>
	<keyword>pharmacist</keyword>
	<keyword>cost-effectiveness</keyword>
</DOC>